MOLINARI, Susanna
 Distribuzione geografica
Continente #
NA - Nord America 4.587
EU - Europa 2.754
AS - Asia 2.742
SA - Sud America 415
Continente sconosciuto - Info sul continente non disponibili 73
AF - Africa 71
OC - Oceania 25
Totale 10.667
Nazione #
US - Stati Uniti d'America 4.466
IT - Italia 994
SG - Singapore 858
CN - Cina 656
GB - Regno Unito 472
VN - Vietnam 381
BR - Brasile 333
SE - Svezia 315
HK - Hong Kong 290
DE - Germania 245
BD - Bangladesh 169
RU - Federazione Russa 112
UA - Ucraina 99
FR - Francia 94
FI - Finlandia 87
KR - Corea 84
NL - Olanda 78
IN - India 67
CA - Canada 66
IE - Irlanda 47
ID - Indonesia 43
TR - Turchia 41
LT - Lituania 34
BE - Belgio 32
BG - Bulgaria 31
MX - Messico 31
AR - Argentina 30
AU - Australia 24
PL - Polonia 23
IQ - Iraq 21
ZA - Sudafrica 21
CZ - Repubblica Ceca 20
JP - Giappone 20
ES - Italia 18
PK - Pakistan 15
MY - Malesia 13
CO - Colombia 11
EC - Ecuador 11
SA - Arabia Saudita 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
TW - Taiwan 10
CL - Cile 9
EG - Egitto 8
JO - Giordania 8
KE - Kenya 8
AT - Austria 7
CH - Svizzera 7
NO - Norvegia 7
UZ - Uzbekistan 7
MA - Marocco 6
PY - Paraguay 6
RS - Serbia 6
CR - Costa Rica 5
IR - Iran 5
VE - Venezuela 5
DO - Repubblica Dominicana 4
IL - Israele 4
JM - Giamaica 4
NG - Nigeria 4
PE - Perù 4
AZ - Azerbaigian 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LV - Lettonia 3
MD - Moldavia 3
NP - Nepal 3
PH - Filippine 3
PT - Portogallo 3
SN - Senegal 3
TH - Thailandia 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
ET - Etiopia 2
GT - Guatemala 2
HU - Ungheria 2
OM - Oman 2
PR - Porto Rico 2
QA - Qatar 2
RO - Romania 2
SC - Seychelles 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AW - Aruba 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
Totale 10.585
Città #
Ashburn 552
Singapore 529
Santa Clara 454
Fairfield 316
Hong Kong 284
San Jose 253
Chandler 248
Southend 248
Woodbridge 213
Hefei 179
Ann Arbor 148
Modena 140
Nyköping 139
Houston 132
Wilmington 131
Ho Chi Minh City 129
Seattle 123
Los Angeles 122
Beijing 117
New York 116
Jacksonville 108
London 105
Council Bluffs 95
Dearborn 90
Cambridge 79
Hanoi 78
Seoul 73
Milan 71
The Dalles 62
Helsinki 58
Chicago 52
Rome 50
Bologna 49
Shanghai 43
Moscow 37
São Paulo 37
Dublin 34
San Diego 34
Munich 33
Jakarta 32
Sofia 30
Buffalo 29
Fremont 28
Princeton 28
Lauterbourg 27
Dallas 25
Toronto 24
Brussels 23
Da Nang 23
Phoenix 22
Enschede 20
Florence 20
Orem 20
Salt Lake City 20
Eugene 18
Izmir 18
Reggio Emilia 18
Denver 17
Haiphong 16
Chennai 15
Formigine 15
Frankfurt am Main 15
Montreal 15
Stockholm 15
Tokyo 15
Brno 14
Brooklyn 14
Columbus 14
Johannesburg 14
Warsaw 14
Amsterdam 13
Elk Grove Village 13
Naples 13
Redwood City 12
Rio de Janeiro 12
Turin 12
Atlanta 11
Bremen 11
Mexico City 11
Boston 10
Dong Ket 10
Parma 10
Poplar 10
Biên Hòa 9
Boardman 9
Dhaka 9
Fuzhou 9
Grafing 9
Mumbai 9
Southwark 9
Bari 8
Belo Horizonte 8
Guarulhos 8
Kent 8
Amman 7
Basingstoke 7
Des Moines 7
Hải Dương 7
Jinan 7
Kunming 7
Totale 6.664
Nome #
IL FATTORE DI TRASCRIZIONE MEF2C AI CROCEVIA TRA PROLIFERAZIONE, SVILUPPO E DIFFERENZIAMENTO MUSCOLARE 734
Low-density lipoprotein (LDL) receptor/transferrin fusion protein: in vivoproduction and functional evaluation as a potential therapeutic tool forlowering plasma LDL cholesterol. 488
Dynamic Phosphorylation of the Myocyte Enhancer Factor 2Cα1 Splice Variant Promotes Skeletal Muscle Regeneration and Hypertrophy 451
NF-YA splice variants have different roles on muscle differentiation 417
NF-Y splice variants differentially affect skeletal myogenesis 408
Differentiation-dependent lysine 4 acetylation enhances MEF2C binding to DNA in skeletal muscle cells 402
Phosphorylation-dependent degradation of MEF2C contributes to regulate G2/M transition 400
Phosphorylation and alternative splicing of MEF2C, a dual switch function in muscle regeneration 365
A novel complex regulates cardiac actin gene expression through interaction of Emb, a class VI POU domain protein, MEF2D, and the histone transacetylase p300 356
Alternative splicing of transcription factors genes in muscle physiology and pathology 347
PROLINE ISOMERASE PIN1 REPRESSES TERMINAL DIFFERENTIATION AND MYOCYTE ENHANCER FACTOR 2C FUNCTION IN SKELETAL MUSCLE CELLS 341
The in vivo form of the murine class VIPOU protein Emb is larger than that encoded by previously described transcripts 329
Distinct functions of alternatively spliced isoforms encoded by zebrafish mef2ca and mef2cb. Ganassi M, Badodi S, Polacchini A, Baruffaldi F, Battini R, Hughes SM, Hinits Y, Molinari S. Biochim Biophys Acta. 2014 Jul;1839(7):559-70. doi: 10.1016/j.bbagrm.2014.05.003. Epub 2014 May 17. 324
A POTENTIAL ROLE OF MEF2C IN THE MYOGENIC PROGRESSION BESIDE TERMINAL DIFFERENTIATION 309
Proline Isomerase Pin1 represses terminal differentiation and Myocyte Enhancer Factor 2C function in Skeletal Muscle Cells 301
A specific role for the splice variants of the transcription factor NF-Y in modulating the transcriptional activity of the myogenic program 295
Design, Characterization, and In Vitro Assays on Muscle Cells of Endocannabinoid-like Molecule Loaded Lipid Nanoparticles for a Therapeutic Anti-Inflammatory Approach to Sarcopenia 285
PIN1: a putative molecular target to protect skeletal muscle against age-related muscle loss 284
Regulation of Mef2c activity by alternative splicing in zebrafish muscle development 276
Role of the CCAAT-transcription factor NF-Y and its splice variants in myogenic differentiation and muscle regeneration 271
The transcription factor NF-Y participates to stem cell fate decision and regeneration in adult skeletal muscle 260
Metabolome in Tibialis and Soleus Muscles in Wild-Type and Pin1 Knockout Mice through High-Resolution Magic Angle Spinning 1H Nuclear Magnetic Resonance Spectroscopy 203
Induction of Calbindin-D28K by 1,25-dihydroxyvitamin D3 in cultured chicken intestinal cells 202
Development of solid lipid nanoparticles for the delivery of an anti- inflammatory drug to muscle skeletal cells 189
Histone deacetylase functions and therapeutic implications for adult skeletal muscle metabolism 187
Absence of mef2 binding to the A/T-rich element in the muscle creatine kinase (MCK) enhancer correlates with lack of early expression of the MCK gene in embryonic mammalian muscle 183
Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expression 181
Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives 178
Differential response of embryonic and fetal myoblasts to TGF-beta. A possible regulatory mechanism of skeletal histogenesis 168
Linking endocannabinoid system, palmitoylethanolamide, and sarcopenia in view of therapeutic implications 161
Inflammatory-Targeted Lipid Carrier as a New Nanomaterial to Formulate an Inhaled Drug Delivery System 159
Specific binding to vitamin D response elements of chicken intestinal DNA-binding activity is not related to the vitamin D receptor 147
Palmitoylethanolamide-loaded Solid Lipid Nanoparticles for a therapeutic anti-inflammatory approach of Sarcopenia involving ECS 145
Nanoparticulate systems for the delivery of Palmitoylethanolamide to muscle cells 137
Investigating hybrid lipid-PLGA nanoparticles loaded with an endogenous endocannabinoid-like molecule for targeting inflamed muscle 123
The nuclear localization domain of the MEF2 family of transcription factors shows member-specific features and mediates the nuclear import of histone deacetylase 4 116
Phosphorylation-dependent binding of MEF2 to the A/T rich element in the muscle creatine kinase enhancer correlates with lack of expression in embryonic mammalian muscle 92
Design and development of hybrid plga nanoparticles for the co-delivery of trimetazidine and palmitoylethanolamide for the treatment of sarcopenia 90
Investigating Hybrid PLGA-Lipid Nanoparticles as an Innovative Delivery Tool for Palmitoylethanolamide to Muscle Cells 87
Nanoparticle-mediated delivery to skeletal muscle cells of N-palmitoylethanolamide (PEA), an endocannabinoid-like molecule with anti-inflammatory properties 78
Comparative in vitro study of lipid and polymeric nanoparticles for the delivery of PEA to myoblasts. 77
Polymeric nanoparticles as a favorable delivery system to enhance the anti-inflammatory action of N-palmitoylethanolamide (PEA), an endocannabinoid-like molecule 68
Targeted Nanodrugs for Inhaled Therapy of Inflammatory Lung diseases 53
Totale 10.667
Categoria #
all - tutte 36.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.652


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022674 61 50 48 46 21 47 38 36 82 47 137 61
2022/2023821 94 107 57 92 59 103 31 76 81 25 45 51
2023/2024735 31 47 74 54 113 70 103 51 14 22 76 80
2024/20251.986 73 35 110 139 322 299 198 128 210 93 171 208
2025/20264.192 267 142 260 488 648 336 547 234 380 397 243 250
2026/2027120 120 0 0 0 0 0 0 0 0 0 0 0
Totale 10.667